UK Artificial Intelligence In Precision Medicine Market Size & Outlook
Related Markets
UK artificial intelligence in precision medicine market highlights
- The UK artificial intelligence in precision medicine market generated a revenue of USD 83.0 million in 2022 and is expected to reach USD 999.4 million by 2030.
- The UK market is expected to grow at a CAGR of 36.5% from 2023 to 2030.
- In terms of segment, deep learning was the largest revenue generating technology in 2022.
- Natural language processing is the most lucrative technology segment registering the fastest growth during the forecast period.
Artificial intelligence in precision medicine market data book summary
| Market revenue in 2022 | USD 83.0 million |
| Market revenue in 2030 | USD 999.4 million |
| Growth rate | 36.5% (CAGR from 2022 to 2030) |
| Largest segment | Deep learning |
| Fastest growing segment | Natural language processing |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
| Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
Other key industry trends
- In terms of revenue, UK accounted for 6.6% of the global artificial intelligence in precision medicine market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK artificial intelligence in precision medicine market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 999.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Precision Medicine Market Scope
Artificial Intelligence In Precision Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Enlitic | View profile | 51-100 | San Francisco, California, United States, North America | http://www.enlitic.com/ |
| BioXcel Therapeutics Inc | View profile | 74 | 555 Long Wharf Drive, New Haven, CT, United States, 06511 | https://www.bioxceltherapeutics.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Alphabet Inc Class A | View profile | 180895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | https://www.abc.xyz |
| NVIDIA Corp | View profile | 29600 | 2788 San Tomas Expressway, Santa Clara, CA, United States, 95051 | https://www.nvidia.com |
| Microsoft Corp | View profile | 221000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | https://www.microsoft.com |
| International Business Machines Corp | View profile | 282200 | One New Orchard Road, Armonk, NY, United States, 10504 | http://www.ibm.com |
| Intel Corp | View profile | 124800 | 2200 Mission College Boulevard, Santa Clara, CA, United States, 95054-1549 | https://www.intel.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
UK artificial intelligence in precision medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.86% in 2024. Horizon Databook has segmented the UK artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The rising incidence of rare diseases is expected to accelerate the market expansion in the country. The development of several therapeutic activities and individualized medical treatments has been made possible by advancements in our understanding and correlation of the properties of the human genome.
In February 2020, Benevolent AI, an AI startup based in the UK, published two studies, one in The Lancet and one in The Lancet Infectious Diseases, identifying authorized medications that might obstruct the SARS-CoV-2 virus's ability to replicate.
The company's AI system found six drugs that successfully block a cellular route that let the virus enter cells to replicate new virus particles using a massive collection of medical data, including data gathered from the scientific literature by ML.
Reasons to subscribe to UK artificial intelligence in precision medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK artificial intelligence in precision medicine market databook
-
Our clientele includes a mix of artificial intelligence in precision medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK artificial intelligence in precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into UK artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK artificial intelligence precision medicine market report size, by technology, 2017-2030 (US$M)
UK Artificial Intelligence In Precision Medicine Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
